CHRS vs AAPL: Which Stock is Better?
Side-by-side comparison of Coherus Oncology Inc and Apple Inc in 2026
CHRS
Coherus Oncology Inc
$1.99
AAPL
Apple Inc
$271.65
Key Metrics Comparison
| Metric | CHRS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $296.78M | N/A | CHRS |
| P/E Ratio | N/A | 34.61 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | 0.6% | 0.2% | CHRS |
| Gross Margin | 67.2% | 47.3% | CHRS |
Analyze CHRS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or AAPL a better investment?
Comparing CHRS and AAPL: Coherus Oncology Inc has a market cap of $296.78M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and AAPL?
CHRS (Coherus Oncology Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or AAPL?
CHRS has higher revenue growth at 0.6% vs 0.2% for AAPL.
Which company is more profitable: CHRS or AAPL?
Coherus Oncology Inc (CHRS) has higher gross margins at 67.2% compared to 47.3% for AAPL.
Which is the larger company: CHRS or AAPL?
Coherus Oncology Inc (CHRS) is larger with a market cap of $296.78M compared to N/A for AAPL.
Should I buy CHRS or AAPL in 2026?
Both CHRS and AAPL have investment merit. CHRS trades at $1.99 while AAPL trades at $271.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and AAPL stock?
Key differences: Market Cap ($296.78M vs N/A), P/E Ratio (N/A vs 34.6x), Revenue Growth (0.6% vs 0.2%), Gross Margin (67.2% vs 47.3%).